Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapyMin Hye Noh, Ji Young Yoo, Minxin Huang et al.|Neuro-Oncology|2024Cited by 22
esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activationJessica Swanner, Ji Young Yoo, Ji Seon Shim et al.|Molecular Therapy — Oncolytics|2023Cited by 10